Stock listing
NASDAQ:AVEO AVEO Pharmaceuticals Inc Stock
Follow AVEO Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:AVEO
$15.00 USD
Close on Jan 20, 2023 · No longer trades
- Lowest – highest close
- $2.60 – $15.28 USDSince Feb 20, 2020 · lowest Mar 18, 2020 · highest Mar 10, 2021
Delisted NASDAQ:AVEO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AVEO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
AVEO Pharmaceuticals Inc on 6ix
- Calls
- 6 calls with a replay · 6 with a transcript · latest Aug 4, 2022
- Decks
- 27 decks · latest Aug 9, 2022
Events
| Call | When | Status |
|---|---|---|
| AVEO Pharmaceuticals (AVEO) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 4:30 PM ET | Replay |
| AVEO Pharmaceuticals (AVEO) Q1 2022 Earnings Call | Thu, May 05, 2022 · 8:30 AM ET | Replay |
| AVEO Pharmaceuticals (AVEO) Q4 2021 Earnings Call | Mon, Mar 14, 2022 · 8:30 AM ET | Replay |
| AVEO Pharmaceuticals (AVEO) Q3 2021 Earnings Call | Mon, Nov 08, 2021 · 4:30 PM ET | Replay |
| AVEO Pharmaceuticals (AVEO) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 4:30 PM ET | Replay |
| AVEO Pharmaceuticals (AVEO) Q1 2021 Earnings Call | Mon, May 10, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2022) | Investor deck | 44 slides | Aug 9, 2022 |
| Investor Presentation (May 2022) | Investor deck | 46 slides | May 6, 2022 |
| Investor Presentation (March 2022) | Investor deck | 47 slides | Mar 14, 2022 |
| Investor Presentation (July 2021) | Investor deck | 47 slides | Jul 16, 2021 |
| Investor Presentation (July 2020) | Investor deck | 26 slides | Jul 6, 2020 |
| Corporate Update (May 2020) | Corporate update | 25 slides | May 29, 2020 |
| Investor Presentation (November 2019) | Investor deck | 36 slides | Nov 5, 2019 |
| Investor Presentation (October 2019) | Investor deck | 34 slides | Oct 3, 2019 |
| Investor Presentation (September 2019) | Investor deck | 31 slides | Sep 10, 2019 |
| Investor Presentation (February 2019) | Investor deck | 34 slides | Feb 15, 2019 |
All 27 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John H. Johnson Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past) | Director · Feb 1, 2018 – Feb 1, 2018 · Past |
| Douglas G Cole Other companies: Foghorn Therapeutics Inc. (Director · Since at least Oct 22, 2020); Sana Biotechnology, Inc. (Director · Feb 3, 2021 – Jun 6, 2024 · Past); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 1, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Jan 2, 2019 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Aug 17, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Aug 10, 2016 · Past); Receptos Inc (Director · May 8, 2013 – Jul 17, 2013 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Mar 25, 2013 · Past) | Director · Mar 11, 2010 – May 12, 2011 · Past |
| Robert C Young Other companies: Human Genome Sciences Inc (Director · May 17, 2012 – Jul 30, 2012 · Past); West Pharmaceutical Services, Inc. (Director · Sep 30, 2011 – Sep 30, 2011 · Past) | Director · May 30, 2012 – Jun 10, 2020 · Past |
| David Brannon Johnston Other companies: ImmunoGen Inc (Chief Financial Officer · Dec 30, 2013 – Jun 6, 2018 · Past) | Chief Financial Officer · Mar 11, 2010 – Oct 2, 2013 · Past |
| Michael P. Bailey Other companies: Verastem, Inc. (Board Member · Since at least May 21, 2026) | President & CEO, Director · Jun 26, 2013 – Jan 19, 2023 · Past |
| Kevin Joseph Cullen | Director · Apr 15, 2021 – Jan 19, 2023 · Past |
| Michael Ferraresso | Chief Commercial Officer · Mar 10, 2021 – Jan 19, 2023 · Past |
| Michael N Needle | Chief Medical Officer · Jan 9, 2015 – Feb 5, 2021 · Past |
Log in to ask 6ix AI your own questions about AVEO Pharmaceuticals Inc.